Quack’s ‘Treatment’ Paralyses 68-Year-Old Woman In Telangana

HYDERABAD:  A 68-year-old woman from Tandur was left bedridden, with total loss of sensation in one leg, after receiving ‘treatment’ from a quack two months ago. The case came to light on Friday after the woman’s family got into an altercation with the accused.

On learning of the malpractice, Telangana State Medical Council (TGMC) is taking it up as a suo moto case to file an FIR against the unqualified practitioner, Mukith.Mukith had been under TGMC’s radar and escaped a raid at his clinic a fortnight ago. He managed to flee from his clinic in Daulatabad in Vikarabad, where he had administered three steroid injections to the patient, Lakshmibai, who had sought treatment from him for knee pain.

‘Quack gave woman 3 steroid injections’

The injections Mukith administered led to sepsis of the knee joint, a swollen leg and fever.

Lakshmibai was rushed to another doctor who performed surgery to remove the infected tissue.

Orthopaedic surgeon Dr Santosh Kumar, who is treating Lakshmibai, said: “She was given three steroid injections in the knee joints. These injections are prescribed only for certain conditions… When she came to me, her entire knee joint was damaged due to sepsis. The family also lost all their money in getting treatment from the quack. Although her leg was saved, it is completely unstable and has no sensation…”

Mukith was among the seven unqualified practitioners raided a fortnight ago by TGMC officials. Six FIRs were lodged after the raids in Parigi, Moinabad, and Daulatabad areas. “We had prescriptions of Mukith, but when the raid started in Daulatabad, he got the information through their network. He shut down the clinic and fled,” said TGMC chief Dr G Srinivas.

Related Posts

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Gujarat based Senores Pharmaceuticals Ltd on Monday, December 15, announced that it has entered into a share purchase agreement to acquire a 100% equity stake in Apnar Pharma Private Ltd.…

Aytu BioPharma launches depression drug EXXUA in U.S. market

DENVER-  Aytu BioPharma, Inc. (NASDAQ:AYTU) announced Monday the commercial availability of EXXUA in the United States for the treatment of major depressive disorder (MDD). The small-cap biotech, with a market…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

ITS in AMTZ, 70 Countries participated for Future of Health Technology

ITS in AMTZ, 70 Countries participated for Future of Health Technology

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session